PharmaVOICE - 
June 2010
Purchase Issue

In Every Issue
Last Word
GLOBAL NEEDS What do you think is the biggest global [...]
By
Talent Pool
Pharmaceutical POOL Dr. Roger POMERANTZ Merck Appoints Head of Infectious [...]
By
E-Media
New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: [...]
By
What’s New
SciQuest has launched the Procurement Business Assessment, a service that [...]
By
PharmaTrax
n The value of the global market for therapeutic vaccines [...]
By
PharmaOutlet
Reputation malaise has made the U.S.-based pharmaceutical industry vulnerable to [...]
By

Gil Bashe, Executive VP, Makovsky + Company

UpFront
Awards CURE Awards ­Bioscience Achievements Pfizer was awarded the CURE [...]
By
Raise Your Voice
A personal journey Many of you are no doubt in [...]
By
Letter from the Editor
Generics coming home to roost… By now, everyone in the [...]
By

Taren Grom, Editor

On The Cover

Adaptive by Design
Adaptive trial designs have the potential to speed development and reduce overall costs — that is, if sponsors invest in up-front planning and can implement these designs correctly. Interest in adaptive designs has risen in recent years. These types of studies involve a broad class of methods and can have a positive impact on any [...]
By

Denise Myshko

Features

ACRP 2010 Global Conference & Exhibition Wrap Up
The Association of Clinical Research Professionals (ACRP) remains steadfast in its mission to provide value and excellence to conference participants against a backdrop of continued economic and regulatory challenges to individuals and businesses. This year’s conference featured 55 sessions and 226 speakers.
By
2010 DIA Preview
PharmaVOICE is pleased to once again publish this Special Feature showcasing the new products, services, tools, and executive appointments and promotions at clinical-services ­companies that will be exhibiting at the DIA 46th Annual Meeting, June 13-17, 2010, in Washington, D.C. For your convenience, we’ve divided the briefs into sections, including E-Solutions, What’s New, and People. [...]
By

Taren Grom, Editor

View on Diversity in Clinical Trials
Rapidly changing demographics are shifting the texture and fabric of American society. So-called niche markets have become “minority-majority” markets. Current healthcare reform that is focusing on better outcomes will only place more pressure on study sponsors to demonstrate to regulators that their clinical trials include all of the populations that will actually use the prescription [...]
By

Kathleen B. Drennan, President and CEO, TrialAdvance, The Face of Clinical Trials; and Sheila L. Thorne, President and CEO, Multicultural Healthcare Marketing Group LLC

Dr. Nancy Simonian: One for All
There’s no place for the arch ego in today’s most progressive biotechnology companies or for that matter, at pharmaceutical companies. Rather, scientific leaders such as Nancy Simonian, M.D., are leading the charge toward collaborative ingenuity. Teamwork is very much Dr. Simonian’s mantra. Indeed, it is the collaborative spirit of biotechnology that spurred Dr. Simonian to [...]
By

Kim Ribbink

The Power of the Cloud
When Dave Powers, senior systems engineer, research and development IT at Eli Lilly and Company, talks about the advantages of cloud computing in the life-sciences industry, he gets pretty excited — as do others who have experienced first hand the benefits of the cloud. According to our thought leaders, cloud computing is game changing in [...]
By

Robin Robinson

Mixed Media: The Best Ways to Reach Physicians in 2010
When considering how to successfully communicate with each physician, it is vital to consider individual physicians, their specialty, their current use of technology, their comfort level for learning new technologies, and their personal preferences for receiving information, says Cherie Hicks, president of CMR Institute. “Ultimately, successful communication is dependent on the message, regardless of the [...]
By

Robin Robinson

FEEDBACK